Baird Financial Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,778
| Closed | -$2.07M | – | 1816 |
|
|
2024
Q3 | $2.07M | Buy |
+5,778
| New | +$2.07M | ﹤0.01% | 953 |
|
|
2019
Q3 | – | Sell |
-10,602
| Closed | -$828K | – | 1556 |
|
|
2019
Q2 | $828K | Sell |
10,602
-21,224
| -67% | -$1.66M | ﹤0.01% | 1051 |
|
|
2019
Q1 | $3.74M | Sell |
31,826
-147
| -0.5% | -$17.3K | 0.02% | 513 |
|
|
2018
Q4 | $3.48M | Sell |
31,973
-3,189
| -9% | -$347K | 0.02% | 494 |
|
|
2018
Q3 | $4.43M | Buy |
35,162
+728
| +2% | +$91.7K | 0.03% | 474 |
|
|
2018
Q2 | $3.9M | Sell |
34,434
-83
| -0.2% | -$9.39K | 0.03% | 488 |
|
|
2018
Q1 | $3.88M | Buy |
34,517
+4,498
| +15% | +$505K | 0.03% | 471 |
|
|
2017
Q4 | $4.44M | Buy |
30,019
+229
| +0.8% | +$33.9K | 0.03% | 442 |
|
|
2017
Q3 | $3.49M | Buy |
29,790
+1,128
| +4% | +$132K | 0.03% | 490 |
|
|
2017
Q2 | $3.72M | Buy |
28,662
+2,284
| +9% | +$296K | 0.03% | 465 |
|
|
2017
Q1 | $3.57M | Sell |
26,378
-511
| -2% | -$69.2K | 0.03% | 468 |
|
|
2016
Q4 | $3.86M | Buy |
26,889
+3,981
| +17% | +$571K | 0.03% | 428 |
|
|
2016
Q3 | $2.71M | Buy |
22,908
+4,766
| +26% | +$563K | 0.02% | 494 |
|
|
2016
Q2 | $1.92M | Buy |
18,142
+8,005
| +79% | +$848K | 0.02% | 560 |
|
|
2016
Q1 | $1.13M | Sell |
10,137
-348
| -3% | -$38.8K | 0.01% | 686 |
|
|
2015
Q4 | $1.64M | Sell |
10,485
-1,403
| -12% | -$220K | 0.02% | 576 |
|
|
2015
Q3 | $1.56M | Buy |
11,888
+686
| +6% | +$90K | 0.02% | 583 |
|
|
2015
Q2 | $1.95M | Buy |
+11,202
| New | +$1.95M | 0.02% | 557 |
|